Speaker illustration

undefined undefined undefined

Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Event: ESC Congress 2022

Topic: Treatment

Session type: Official Joint Session

Thumbnail

Changing the journey of patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

How Should I Treat Cardiac Amyloidosis?

Event: ESC Congress 2020

Topic: Myocardial Disease

Session type: Special Session

Thumbnail

Hot topics in myocardial and pericardial diseases

Event: ESC Congress 2019

Topic: Clinical

Session type: Rapid Fire Abstracts

Thumbnail

Cracking the code to a differential diagnosis of cardiac amyloidosis

Event: Heart Failure 2019

Topic: Clinical

Session type: Satellite Symposium

Thumbnail

Expert Advice - Pragmatic approaches in challenging cardiomyopathies

Event: ESC Congress 2018

Topic: Clinical

Session type: Expert Session

Thumbnail

Have you considered cardiac amyloidosis in your patients?

Event: ESC Congress 2018

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Considering cardiac amyloidosis in our patients: why is it so important?

Event: Heart Failure 2018

Topic: Myocardial Disease

Session type: Satellite Symposium

Thumbnail

The myocarditis challenge

Event: ESC Congress 2016

Topic: Myocarditis

Session type: Advances in Science

Thumbnail

ESC 365 is supported by